Clinical Trials Browser

Phase 1/2 × Interventional × VPM1002 recombinant BCG vaccine × Clear all

NCT02371447 2023-04-13

VPM1002BC in Recurrent Non-muscle Invasive Bladder Cancer

Phase 1/2 Completed

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms